MetaCap

Immutep Statistics

NASDAQ: IMMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.11-0.31 (-9.06%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Immutep by the numbers

Immutep has a market capitalization of $22.9 million based on 7.37M shares outstanding. With trailing EPS of $-7.30, Immutep is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.6% below its 50-day average and 75.8% below its 200-day average.

Average daily trading volume is 26.07K shares, or about $81,062 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

IMMP valuation vs. peer median

IMMP compared with the median of 8 peer companies
MetricIMMPPeer medianDifference
Market cap$22.92M$23.23M-1%
Avg. volume26.07K158.44K-84%

Peer median across 8 companies: RMTI, IXHL, ABVC, SCYX, CRVO, LITS, AARD, RNAZ.

Valuation

Price and trading

Previous close
3.42
Open
3.41
Day range
3.09 – 3.41
52-week range
2.66 – 70.60
52-week change
+80.81%
Beta
—
Volume
44.77K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
22.92M
Forward Pe
-0.96
Eps
-7.30
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
70.60
Week52 Low
2.66
Avg Volume
26,065.00
Shares Outstanding
7.37M
Ma50
4.02
Ma200
12.83
Earnings Date
Sep 3, 2026
Pct From52w High
-95.59%
Pct From52w Low
16.92%

Related